APIM050058: PD-1 INHIBITOR 16 (AURIGENE COMPOUND 16)
CAS No.: 2005454-12-4.
Purity: >99.5% by HPLC (at 214 nm).
QC: HPLC, 1H-NMR, Quantitative Elemental Analysis Report.
Solubility: Refer to Certificate of Analysis.C043P: Daclizumab Biosimilar, CD25 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade daclizumab biosimilar specifically binds to the human interleukin-2 receptor (anti-Tac or anti-CD25).
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by daclizumab.